AI TextQuick Glance (AI)Headnote
Issues: (i) Whether FOB value of deemed exports is liable to be added to physical exports for determining DTA sales entitlement; (ii) Whether goods can be sold or cleared in DTA by more than 90% of the FOB value of export of a particular product; (iii) Whether goods sold by the appellant in DTA are similar to those exported by it, or whether any goods were cleared only in DTA; (iv) Whether extended period was rightly invoked for demanding duty for the larger period.
Issue (i): Whether FOB value of deemed exports is liable to be added to physical exports for determining DTA sales entitlement?
Analysis: The entitlement under the relevant Foreign Trade Policy was examined in the light of prior decisions holding that deemed exports form part of the FOB value for computing DTA sale entitlement. The entitlement had to be rechecked with reference to the practice adopted by the Development Commissioner and the policy position applicable during the relevant period.
Conclusion: The issue was answered in favour of the assessee, and the matter was required to be reconsidered on that basis.
Issue (ii): Whether goods can be sold or cleared in DTA by more than 90% of the FOB value of export of a particular product?
Analysis: The policy was read as permitting DTA sale of any specific product up to 90% of the FOB value of export of that product, provided the overall DTA entitlement of 50% of FOB value of exports is not exceeded. The factual position as to whether this limit was breached for any specific product required fresh verification.
Conclusion: The issue was not finally decided on merits and was remitted for fresh determination.
Issue (iii): Whether goods sold by the appellant in DTA are similar to those exported by it, or whether any goods were cleared only in DTA?
Analysis: The question of similarity was held to be fact-sensitive and technical in the context of pharmaceutical products. The comparison was directed to be made on composition, use, trade or proprietary name, and other relevant technical parameters, with the assessee permitted to support its case by accepted pharmacopoeias or product-patent based material.
Conclusion: The issue was left for reconsideration by the adjudicating authority.
Issue (iv): Whether extended period was rightly invoked for demanding duty for the larger period?
Analysis: The returns and periodic intimations filed by the assessee did not disclose the detailed questions of similarity, entitlement, and carried-forward balance that surfaced only upon audit scrutiny. On that basis, the earlier finding that the suppression-based extended period was invocable was accepted.
Conclusion: The invocation of extended period was upheld.
Final Conclusion: The appeal succeeded only to the extent that the matter was sent back for fresh adjudication of the entitlement and product-similarity questions, while the finding on limitation was sustained.
Ratio Decidendi: In computing EOU DTA sale entitlement, deemed exports may be relevant to FOB value, product-wise 90% limits operate subject to the overall entitlement cap, and product similarity in pharmaceutical goods must be determined on technical parameters; failure to disclose relevant entitlement facts in returns may justify extended limitation.
DTA sale entitlement and product similarity under export policy turn on deemed exports, technical comparison, and disclosure in returns.
Deemed exports may be included in FOB value for computing DTA sale entitlement under the relevant Foreign Trade Policy, and product-wise DTA sales are limited to 90% of the FOB value of exports of that product, subject to the overall entitlement cap. In pharmaceutical cases, similarity between exported and DTA-cleared goods is a fact-sensitive technical inquiry based on composition, use, trade or proprietary name, and other relevant parameters, with supporting pharmacopoeial or patent-based material permitted. Where returns and intimations did not disclose the entitlement and similarity issues later found on audit, invocation of the extended limitation period was upheld.
DTA sales entitlement - deemed exports treated as physical exports for FOB calculation - 90% FOB limit for specific product within overall 50% DTA entitlement - similar goods (Customs Valuation definition applied to DTA sales) - extended period of limitation invoked on discovery/suppression in audit - Entitlement to demand differential duty under Notification No. 23/2003-CE - HELD THAT:- We find that the appellant has claimed and also supported by various case laws that FOB value of deemed exports should be included in FOB value of physical exports for determining the DTA sales entitlement. We have gone into various case laws and find that the contention of the appellant is correct. In the case of M/s Shree Rohini Enterprises Vs Commissioner of Central Excise, Surat-I, this tribunal [2006 (11) TMI 677 - CESTAT AHMEDABAD], held that the value of deemed export is also to be taken into account for determining 50% of the FOB value which will be permitted to be sold to domestic market. Therefore, this issue needs relook by the learned Adjudicating Authority and he may re-check with the office of the Development Commissioner regarding the practice adopted by them as per EXIM Policy as stood at the relevant time, before determining whether the appellant has exceeded DTA sales beyond their entitlement to demand differential duty under Notification No. 23/2003-CE dated 31.03.2003. Limit on DTA sale - HELD THAT:- We find that there is a limit on DTA sale of any specific product not more than 90% of the FOB value of export of that particular product subject to not exceeding overall DTA sales entitlement of 50% of FOB value of exports. In fact, wastes, and by products etc if intended to be cleared in DTA, are also to remain within the overall limit of 50% of the FOB value of exports. We therefore, are not convinced with the arguments of the appellant and accordingly, remit this matter to the learned Adjudicating authority to see if this limit has been breached in respect of DTA sales of any specific product. In case, this condition has been breached in respect of any specific product, the appellant shall be liable to pay excise duty as per the relevant provisions. Invocation of extended period - HELD THAT:- We however, find from their ER-2 returns that consolidated figures/details of goods cleared in DTA sale are mentioned whereas issues involved in the present case have arisen after deeper scrutiny of documents of the Appellant by the officers. The issues such as similarity of the products, DTA sales entitlement with reference to exports and carried forward balance of entitlement at the close of the previous quarter, cannot be known from the details provided by the appellant in their ER-2 returns and/or in other intimations. These were known to the department only when appellant’s records were audited by the officers which otherwise would have remained unnoticed. In para 4.9 of his order, Learned Commissioner has discussed this issue in detail and justified invocation of extended period in this case. Thus, we agree with the findings of the learned Adjudicating authority on this issue and hold that extended period of limitation has correctly been invoked. Thus, we remit the matter to the Adjudicating Authority for deciding various issues raised by the appellant afresh in the light of above observations and then, re-determine central excise duty liability on the appellant, if any. The appeal is allowed by way of remand.